文献速递脊柱关节炎

解读难治性银屑病关节炎:来自银屑病关节炎患者国际调查的洞见

Deciphering difficult-to-treat psoriatic arthritis: insights from an international survey of patients with psoriatic arthritis.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

该研究由GRAPPA发起,采用10种语言的在线调查,收集570例银屑病关节炎患者对治疗无效的看法。持续性关节疼痛和银屑病(65.7%)、疲劳(52.8%)及药物副作用(41.7%)是难治性和复杂管理型PsA的主要因素,66.4%报告睡眠受损和生活乐趣减少。

要点

  • 570例受访者中,持续性关节疼痛和银屑病(65.7%)、疲劳(52.8%)、药物副作用(41.7%)是难治性/复杂管理型PsA的主要因素。
  • 按影响排序,关节炎是最令人衰弱的症状;66.4%报告睡眠受损和生活乐趣减少。
  • 荷兰受访者优先关注疲劳,意大利受访者优先关注日常生活影响,显示语言差异。

核心结论

  • 这是首个强调患者驱动洞见的难治性PsA管理国际研究,强调考虑生物学和心理社会因素的多维度方法,将为GRAPPA标准化治疗抵抗性PsA定义提供信息。

研究设计与样本

  • 由GRAPPA成员与患者研究伙伴合作开发的多语言(10种语言)在线调查,包含人口学数据、治疗失败结构化问题和开放式问题,使用描述性统计和Dedoose对定性回答进行归纳编码,共570例受访者。

主要发现

  • 570例受访者中大多数为女性(68.8%)和白人(72.6%),PsA平均诊断延迟4.3年。
  • 难治性和复杂管理型PsA的主要因素为持续性关节疼痛和银屑病(65.7%)、疲劳(52.8%)和药物副作用(41.7%)。
  • 按影响排序,关节炎是最令人衰弱的症状;66.4%报告睡眠受损和生活乐趣减少。
  • 荷兰受访者优先关注疲劳,意大利受访者优先关注日常生活影响。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Psoriatic arthritis (PsA) is a heterogeneous inflammatory disease in which a significant proportion of patients remain refractory to existing therapies. The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) initiated a project aimed at unravelling the reasons for treatment failures in PsA, culminating in the establishment of definitions for difficult-to-treat PsA (D2T-PsA) and complex-to-manage PsA (C2M-PsA). This study explores patient perspectives on treatment-resistant PsA, incorporating a broader patient perspective into the overarching GRAPPA project. METHODS: A multilingual (10 languages), online survey to explore PsA patients' perspectives on treatment inefficacies was used. It was developed collaboratively by GRAPPA members and patient research partners. It included sections on demographic data, structured questions about treatment failures, and open-ended questions. Data analysis used descriptive statistics and inductive coding of qualitative responses via Dedoose. RESULTS: Among 570 respondents, most were female (68.8%) and White (72.6%), with an average PsA diagnosis delay of 4.3 years. Key contributors to D2T- and C2M-PsA were persistent joint pain and psoriasis (65.7%), fatigue (52.8%) and medication side effects (41.7%). Ranked by impact, arthritis was the most debilitating symptom. Quality of life concerns were notable, with sleep impairment and reduced life enjoyment being reported by 66.4%. Language differences emerged; for instance, Dutch and Italian respondents prioritized fatigue and daily life impact, respectively. CONCLUSION: This is the first international study to highlight patient-driven insights in the management of resistant PsA, emphasizing a multidimensional approach that considers biological and psychosocial factors. These insights will inform the ongoing GRAPPA initiative to standardize definitions for treatment-resistant PsA, ultimately improving patient care.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Ribeiro AL, Singla S, Hay-Rollins C, et al. Deciphering difficult-to-treat psoriatic arthritis: insights from an international survey of patients with psoriatic arthritis. Rheumatology (Oxford). 2025. PMID: 40221862. doi:10.1093/rheumatology/keaf207

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。